Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
突变型 KRAS 疫苗联合双重检查点阻断治疗切除的胰腺癌:一项 I 期试验。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68324-4
Huff Amanda L, Haldar S Daniel, Gergis Alexander A, Wang Hejia Henry, Danilova Ludmila, Heumann Thatcher, Berg Maureen, Wang Yuxuan, Andaloori Lalitya, Hernandez Alexei, Longway Gabriella, Barrett Benjamin, Zhu Zirui, Davis-Marcisak Emily, Thoburn Christopher, Leatherman James, Mitchell Sarah, Lee Jae W, Shu Daniel H, Konig Maximillian F, Mog Brian J, Montagne Janelle, Coyne Erin M, Bever Katherine, Baretti Marina, Yarchoan Mark, Anders Robert A, Kagohara Luciane T, Laheru Daniel, Thomas Amy M, Durham Jennifer, Nauroth Julie M, Lu Jiayun, Wang Hao, Fertig Elana J, Ho Won Jin, Azad Nilofer S, Jaffee Elizabeth M, Zaidi Neeha